Remove Develop Remove Pasadena Remove Patents Remove Sales
article thumbnail

Arrowhead Buys RNAi Research and Development Assets From Novartis

socalTECH

Pasadena-based Arrowhead Research said this morning that it has acquired the entire RNAI research and development portfolio and associated assets of Novartis. Arrowhead said the deal also includes milestones and royalties on sales of future products. READ MORE>>.

Research 100
article thumbnail

Materia Faces Legal Challenge From German Company

socalTECH

Pasadena-based material science technology developer Materia appears to be facing some legal challenges in court, according to Law360. patent infringement verdict over a chemical bond component Materia makes in January, and claims that Materia is still offering those infringing products for sale on its website.

Company 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Interview with Marcus Filipovich, Ocular Data Systems

socalTECH

Last week, Pasadena-based Ocular Data Systems (www.oculardatasystems.com) announced a funding round from the Pasadena Angels, for its camera-based systems used by law enforcement to capture evidence in drunk or drugged driving cases. That's a bridge to our Series A, which we'll be using for scaling up sales and marketing.

article thumbnail

How Beatshare Is Tackling Music And Messaging

socalTECH

Orange County startup Beatshare --backed by the Tech Coast Angels, Pasadena Angels, Harvard Business School Angels, and Archangels, among others�thinks it's figured out the formula to make music the message in its mobile app. Barry Lieberman: My backgruond is about 35 years in technology, business development, and sales and marketing.

article thumbnail

Bio Roundup: Trump’s Triumph, Election Fallout, CRISPR Arguments & More

Xconomy

CRISPR DEVELOPMENTS. —Oral arguments in the landmark patent fight over ownership of the gene editing technology CRISPR-Cas9 were set for Dec. Patent and Trademark Office. —Despite the patent fight, CRISPR work continues apace. —Despite the patent fight, CRISPR work continues apace. 6 at the U.S.

Patents 87
article thumbnail

Interview with Cliff Rees, XCast Labs

socalTECH

round of funding from the Pasadena Angels and Frontera Capital for a voice-over-IP service, and we thought we'd talk with Cliff Rees, the firm's CEO, to understand how the firm is different from those many providers. Our CTO, Vladamir, the head of our engineering and core development team, went and formed his own garage R&D company.

IP 165
article thumbnail

3D Printing Redux: How Idealab's New Matter Wants To Bring 3D To The Masses

socalTECH

Pasadena-based New Matter (www.newmatter.com) is developing a 3D printer, the MOD-t, which it says will help bridge the world of 3D printing experimentation with the consumer. What''s unique about the MOD-t, is we have a patent pending motion system for two of our 3 axis of motion.

Idealab 100